Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
-
India's Modi faces key test as vote count underway
-
Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
-
Badminton no.1 An brings 'fire' as South Korea win Uber Cup
-
Saka sparks Arsenal attack into life ahead of Atletico showdown
-
Atletico aim to show Alvarez their ambition in Arsenal semi
-
Seoul, Taipei hit records as Asian stocks track Wall St tech rally
-
Boeing faces civil trial over 737 MAX crash
-
Australian inquiry opens public hearings into Bondi Beach shooting
-
Iran warns of ceasefire violation as US plans to escort Hormuz ships
-
North Korean club to play rare football match in South
-
Pistons rout Magic to cap comeback, book NBA playoff clash with Cavaliers
-
Japan, Australia discuss energy, critical minerals
-
Village braces for closure of Spain's largest nuclear plant
-
GameStop makes $56 billion takeover bid for eBay
-
Ex-NY mayor Giuliani hospitalized in 'critical' condition: spokesman
-
Europe, Canada leaders hold Yerevan talks in Trump's shadow
-
'No pilgrims': regional war hushes Iraq's holy cities
-
Israel court extends detention of two Gaza flotilla activists
-
Massive search continues for two missing US soldiers in Morocco
-
Players keep up battle with tennis majors as they decry Roland Garros prize money
-
EB5 United Surpasses 800 I-526E Approvals in Post-RIA EB-5 Landscape
-
Pistons rout Magic to complete comeback, advance in NBA playoffs
-
Trump says US and Iran in 'positive' talks, unveils plan to escort Hormuz ships
-
Talisman Endrick fires resurgent Lyon into third in France
-
Verstappen laments spin and struggle for pace in Miami
-
Teen Antonelli wins again in Miami to extend title race lead
-
Ferrari's Leclerc admits he threw away Miami podium finish
-
Cristian Chivu, a winner with Inter on the pitch and in the dugout
-
Key players from Inter Milan's Serie A title triumph
-
No.4 Young cruises to PGA title at Doral
-
Vinicius double delays Barca title as Real Madrid down Espanyol
-
Inter Milan win Italian title for third time in six seasons
-
Spurs solved mental frailty to boost survival bid: De Zerbi
-
Miami champ Antonelli shrugs off success, vows 'back to work'
-
Man Utd beat Liverpool, Spurs climb out of relegation zone
-
Spurs out of relegation zone after vital win at Villa
-
No.1 Korda cruises to LPGA Mexico crown
-
Thompson-Herah shines at world relays, Tebogo helps Botswana to win
-
Three die on Atlantic cruise ship from suspected hantavirus: WHO
-
Germany's Merz says not 'giving up on working with Donald Trump'
-
Mercedes' Kimi Antonelli wins Miami Grand Prix
-
Man Utd job feels 'natural' to Carrick
-
Ferguson taken to hospital before Man Utd win against Liverpool
-
'Devil Wears Prada 2' takes top spot in N. America box office
-
Iran weighs US response to peace plan after warning against military action
-
Gladbach sink Dortmund, St Pauli edge closer to drop
-
Rubio to visit Rome, meet Pope Leo after Trump row
-
Kyiv hits Russian oil sites as eight killed in both countries
-
Iran says US military operation 'impossible' as Trump mulls peace proposal
-
Man Utd beat Liverpool to secure Champions League place
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading translational oncology research organization, will report its financial and operational results for the third quarter ended January 31, 2026, on Thursday, March 12, 2026, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 957548. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 53731, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper
Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
T.Ward--AMWN
